TTK Overexpression: A Negative Prognostic Biomarker in Anaplastic Thyroid Carcinoma
Cancer Medicine · 2026-06 · 15 (6)
DOI: 10.1002/cam4.71995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 14.06.2026. Verfasst von Yan Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Qinghai Provincial People's Hospital, Xining City, Qinghai Province, China. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Biomarkers, Tumor, Thyroid Neoplasms, Protein Serine-Threonine Kinases. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Qinghai Provincial Health Commission Guidance Program, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background
Given threonine and tyrosine kinase (TTK)'s oncogenic role in various cancers and its understudied status in thyroid cancer, this study investigates TTK expression in thyroid lesions to assess its diagnostic and therapeutic potential.
Methods
We analyzed differential TTK expression levels using public datasets ( n = 143) and clinical samples ( n = 91) across various thyroid lesions. Prognostic predictions based on TTK expression were conducted using a 2 × 2 contingency table, receiver operating characteristic curve (ROC), and Kaplan–Meier survival analysis.
Results
TTK expression levels increased with the malignancy grade of thyroid lesions. In highly malignant anaplastic thyroid carcinoma (ATC) tissue, both TTK mRNA ( p = 0.003) and protein levels ( p = 0.000) were significantly higher than those in less malignant papillary thyroid carcinoma (PTC). TTK protein expression showed excellent discrimination between benign and malignant thyroid lesions (AUC = 0.983–0.999, p = 0.000). Notably, ATC patients with high TTK protein expression had significantly lower overall survival rates compared to those with low expression, effectively predicting prognosis (AUC = 0.833, p = 0.046).
Conclusion
TTK expression is markedly upregulated in highly malignant ATC tissues compared to benign lesions and PTC. The protein level of TTK emerges as a valuable diagnostic marker for distinguishing between benign and malignant thyroid conditions and serves as a crucial prognostic indicator for ATC. Further exploration and validation of its application in clinical practice are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Qinghai Provincial People's Hospital, Xining City, Qinghai Province, China.
- Medical Service Department, The 960th Hospital of PLA, Jinan, Shandong, China.
- Department of Basic Medical Sciences, The 960th Hospital of PLA, Jinan, Shandong, China.
- Department of Pathology, Lishui Municipal Central Hospital, Lishui City, Zhejiang Province, China.
ORCID-Profile: Yan Guo, Zhidong Sun, Xiao Liu, Yuan Cao
Förderung
- Qinghai Provincial Health Commission Guidance Program
- Natural Science Foundation of Shandong Province
Zitieren
APA
Guo, Y., Sun, Z., Liu, X., Liu, X., Chen, H., Zhang, M., Mao, W., & Cao, Y. (2026). TTK Overexpression: A Negative Prognostic Biomarker in Anaplastic Thyroid Carcinoma. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71995
Vancouver
Guo Y, Sun Z, Liu X, Liu X, Chen H, Zhang M, et al. TTK Overexpression: A Negative Prognostic Biomarker in Anaplastic Thyroid Carcinoma. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71995
BibTeX
@article{Guo2026,
author = {Guo, Yan and Sun, Zhidong and Liu, Xiao and Liu, Xianni and Chen, Haiwen and Zhang, Menglan and Mao, Weibo and Cao, Yuan},
title = {TTK Overexpression: A Negative Prognostic Biomarker in Anaplastic Thyroid Carcinoma},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cam4.71995}
}
EUVIMED